Mounjaro, Elon Musk and Weight Loss

“Looking Good, Santa”: Elon Musk Admits To Using Mounjaro For Weight Loss In “Ozempic Santa” Post
Elon Musk uses the weight-loss drug Mounjaro, he newly revealed, as he jokingly referred to himself as “Ozempic Santa” in a Santa suit. Taking to the social media platform he owns, X (formerly known as Twitter),
Lean-looking Elon Musk reveals he’s taking Mounjaro for weight loss in festive ‘Ozempic Santa’ post
A lean-looking Elon Musk revealed Wednesday that he uses Mounjaro — after previously expressing support for similar weight-loss drugs as a means to curb America’s obesity epidemic.
Elon Musk Reveals He Uses Mounjaro For Weight Loss In Christmas Post
He prefers Mounjaro over Ozempic, another popular GLP-1 inhibitor, due to its fewer side effects and increased effectiveness.
Elon Musk reveals using Mounjaro for weight loss over Ozempic in 'Ozempic Santa' post
A slimmer Elon Musk revealed on Wednesday that he uses Mounjaro, a weight-loss drug, after previously advocating for similar medications as a way to address America’s obesity crisis.
Elon Musk dubs himself "Ozempic Santa" as weight loss drugs go mainstream
Elon Musk showed off a trimmer figure in a holiday social media post on Wednesday while revealing that he has been taking an anti-obesity drug to shed pounds. Why it matters: Musk's post highlighted just how mainstream weight-loss drugs like Ozempic and Wegovy have become in recent years as public figures openly admit to using them,
Elon Musk's Christmas Santa post hints that he prefers Mounjaro over Ozempic for weight loss
Tech billionaire Elon Musk's Christmas post indicates that he prefers taking Mounjaro over Ozempic for weight loss. The Tesla owner has earlier also expressed his support for similar weight-loss drugs as a way to battle the obesity epidemic in America.
Did You See Leaner Elon Musk In XMas Post? All About The Weight-Loss Drug He Claims To Use
Whatever Elon Musk, the CEO of Tesla and SpaceX, says, dons, or does becomes news. On Christmas Day, the man who is the force behind companies like Neuralink, The Boring Company, and X (formerly Twitter) stunned all with a social media post.
Soap Central on MSN9h
What is Mounjaro prescribed for? Elon Musk seemingly reveals taking weight loss drug in his Christmas post
Elon Musk took to X on Wednesday to revel in the Christmas spirit. He also reportedly credited Mounjaro for his weight loss ...
Zepbound and Mounjaro are the two best-in-class products right now, says Dr. Scott Gottlieb
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the future of pharmaceutical advertising, health ...
Lilly obesity drug Mounjaro to be offered in Britain's NHS after watchdog nod
Eli Lilly's obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after ...
FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
'Such A Better Life': Jim Gaffigan Opens Up About Shedding 50 Lbs On 'The View' After Taking Mounjaro
Jim Gaffigan opened up about shedding 50 pounds on The View, sharing a moment with co-host Whoopi Goldberg as they discussed ...
Everyday Health2d
FDA Says Shortages of GLP-1 Drugs Mounjaro and Zepbound Are Over
Tirzepatide, the main ingredient in Mounjaro and Zepbound, is no longer in shortage, according to the U.S. Food and Drug ...
Lilly's Mounjaro more popular than Wegovy in UK's private obesity drug market
Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...
Zepbound, Mounjaro shortages are resolved, FDA confirms
The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a ...
Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...